how do semaglutides help you lose weight Does Wegovy Work for Loss? How Fast Can You Lose

The bioavailability problem Absorption comparison: Injection: 80-100% bioavailability (nearly all absorbed) Nasal spray: 30-70% bioavailability (varies by peptide) Oral: 0-5% bioavailability (most peptides destroyed) Why nasal lower than injection: Must penetrate nasal mucosa (barrier) Some drips down throat (swallowed = lost) Variable absorption efficiency Technique-dependent Individual variation high What this means: You need MORE peptide via nasal spray Typically 2-3x higher dose than injection Example: 1mg injection = 2-3mg nasal Increases cost significantly But still cheaper/easier than injection for some Conversion guidelines by peptide PT-141: Injection: 1.5-2mg typical dose Nasal equivalent: 3-5mg Conversion ratio: 2-3x Semax: Designed for nasal use (no conversion needed) Standard nasal dose: 200-600mcg per spray 2-3 sprays per nostril typical Follow product guidelines BPC-157 (if attempting nasal): Injection: 250-500mcg Nasal (estimated): 750-1500mcg But: Injection or oral likely better Nasal BPC-157 not well-studied General conversion approach: Start with 2-3x injection dose Assess results after 2-3 uses Increase by 25-50% if weak effects Find minimum effective nasal dose Individual variation significant Cost implications: Using 2-3x more peptide = 2-3x cost Nasal spray more expensive per dose Trade-off: Convenience vs cost Worth it for needle-phobic Not worth it if injections acceptable Use peptide cost calculator to compare routes

(Warkus and Marikawa, 2018) demonstrated that neither fluoxetine nor its main metabolite norfluoxetine (norfluoxin) had an effect on cardiomyocytes in the P19C5 embryoid body (EB) model in mice

Understanding Peptide Therapy Testimonial GET IN TOUCH WITH YOUR HEALTH SPECIALISTS Our expertise in peptide therapy and personalised treatments helps optimise wellness and recovery

Your provider will help determine which is safest and most appropriate for you

doi:10.1177/1933719117711262

GABA has been found to be lowered in the plasma and cerebrospinal fluid in patients with depression (Siwek et al